HALLMARK HEALTHCARE CORP
10-Q/A, 1994-12-05
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: NORDSTROM CREDIT INC, 10-Q, 1994-12-05
Next: MERRILL LYNCH GLOBAL RESOURCES TRUST /, N-30B-2, 1994-12-05



<PAGE>

                                   FORM 10-Q/A

                                 AMENDMENT NO. 1

                                       TO

                                QUARTERLY REPORT

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


[ X ]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For The Quarterly Period Ended September 30, 1994

[   ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the Transition Period From __________ To __________

Commission file number 0-13991


                         HALLMARK HEALTHCARE CORPORATION
             (Exact name of registrant as specified in its charter)

           DELAWARE                                         63-0817574
(State or Other Jurisdiction of                          (I.R.S. Employer
Incorporation or Organization)                        Identification Number)

3707 FM 1960 WEST, SUITE 500, HOUSTON, TEXAS                   77068
(Address of Principal Executive Offices)                    (Zip Code)

                                 (713) 537-5230
              (Registrant's Telephone number, Including Area Code)

                                 NOT APPLICABLE
              (Former name, former address and former fiscal year,
                          if changed since last report)

     Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                                Yes  X    No
                                   -----    -----
     The number of shares of the Registrant's Common Stock outstanding at
December 5, 1994:

                 CLASS A COMMON STOCK, $0.05 PAR VALUE - 10,000

<PAGE>

     The registrant is filing this amendment to its Quarterly Report on Form
10-Q, for the quarter ending September 30, 1994 for the sole purpose of adding
Exhibit 27, a Financial Data Schedule to said quarterly report.

                           PART II - OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     Item 6(a) of the registrant's Quarterly Report on Form 10-Q, for the
quarter ending September 30, 1994, is amended in its entirety to read as
follows:

(a)  Exhibits

                                                                      Sequential
        Item     Description                                           Page No.
        ----     -----------                                          ----------

        11       Calculation of Average Number of Common and Common
                 Equivalent Shares (Quarters ended September 30, 1994
                 and 1993)*

        27       Financial Data Schedule (Quarters ending September 30,
                 1994 and 1993)                                             5




- - ----------------
*Filed previously


                                       -2-

<PAGE>

                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                        HALLMARK HEALTHCARE CORPORATION


Date: December 5, 1994

                                        By: /s/ T. MARK BUFORD
                                            -----------------------------------
                                            T. Mark Buford
                                            Vice President and Controller
                                            Principal Accounting Officer


                                       -3-



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE REGISTRANT'S
CONDENSED CONSOLIDATED BALANCE SHEET AT SEPTEMBER 30, 1994 (UNAUDITED), AND
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 1994 (UNAUDITED), AND THE NOTES THERETO, AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1994
<PERIOD-START>                             JUL-01-1994
<PERIOD-END>                               SEP-30-1994
<CASH>                                        $ 21,996
<SECURITIES>                                     1,363
<RECEIVABLES>                                   25,195
<ALLOWANCES>                                     3,786
<INVENTORY>                                      4,206
<CURRENT-ASSETS>                                59,173
<PP&E>                                         167,364
<DEPRECIATION>                                  64,449
<TOTAL-ASSETS>                                 175,371
<CURRENT-LIABILITIES>                           25,985
<BONDS>                                         87,561
<COMMON>                                           167
                            1,390
                                          0
<OTHER-SE>                                      32,830
<TOTAL-LIABILITY-AND-EQUITY>                   175,371
<SALES>                                              0
<TOTAL-REVENUES>                                47,585
<CGS>                                                0
<TOTAL-COSTS>                                   37,966
<OTHER-EXPENSES>                                 2,393 <F1>
<LOSS-PROVISION>                                 2,843
<INTEREST-EXPENSE>                               2,521
<INCOME-PRETAX>                                  1,862
<INCOME-TAX>                                       782
<INCOME-CONTINUING>                              1,080
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,080
<EPS-PRIMARY>                                   $ 0.29
<EPS-DILUTED>                                     0.29
<FN>
<F1>Depreciation
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission